Patent · US Active

IL-13 receptor antibodies

US8318910B2 · kind B2 · utility

0Cited by

7References

8Claims

0Family size

Assignee

Sanofi · FR

Inventors

Daniel Caput · San Francisco, US
Pascual Ferrara · Auterive, FR
Patrick Laurent · Auterive, FR
Natalio Vita · Toulouse, FR

Key dates

Filing date	Feb 15, 2011
Grant date	Nov 27, 2012
Priority date	—
Expiry date	Feb 21, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to monoclonal and polyclonal antibodies capable of specifically recognizing IL-13 receptor α and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.